Literature DB >> 5578488

Platelet function and platelet phospholipids in patients with hyperbetalipoproteinemia. Effect of nicotinic acid and clofibrate.

A Nordoy, J M Rodset.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5578488

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


× No keyword cloud information.
  8 in total

1.  Effect of gemfibrozil upon platelet function and blood coagulation. Preliminary report.

Authors:  V P Rasi; I Torstila
Journal:  Proc R Soc Med       Date:  1976

2.  [Thrombocyte function analysis in hyperlipoproteinemias].

Authors:  H Zöller; A Schramm; W Gross
Journal:  Blut       Date:  1974-01

Review 3.  Platelet activation in normo- and hyperlipoproteinemias.

Authors:  J Nimpf; H Wurm; G M Kostner; T Kenner
Journal:  Basic Res Cardiol       Date:  1986 Sep-Oct       Impact factor: 17.165

4.  [The influence of insulin, glucose and other monosaccharides on the platelet functions (author's transl)].

Authors:  D Wamhoff; G Panzram
Journal:  Klin Wochenschr       Date:  1976-12-01

Review 5.  [Coagulation and fibrinolytic system in the vascular risks diabetes mellitus and hyperlipoproteinemia (author's transl)].

Authors:  H Zöller
Journal:  Klin Wochenschr       Date:  1978-08-15

6.  Contrasting patterns of coronary atherosclerosis in normocholesterolaemic smokers and patients with familial hypercholesterolaemia.

Authors:  D D Sugrue; G R Thompson; C M Oakley; I M Trayner; R E Steiner
Journal:  Br Med J (Clin Res Ed)       Date:  1981-11-21

7.  Native and modified low-density-lipoprotein interaction with human platelets in normal and homozygous familial-hypercholesterolaemic subjects.

Authors:  A Shmulewitz; J G Brook; M Aviram
Journal:  Biochem J       Date:  1984-11-15       Impact factor: 3.857

8.  Platelet changes after a saturated fat meal and their prevention by Dazmegrel, a thromboxane synthetase inhibitor.

Authors:  J J Belch; A R Saniabadi; K McLaughlin; C D Forbes
Journal:  Lipids       Date:  1987-03       Impact factor: 1.880

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.